Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 922

1.

Implementing a sustainable medication reconciliation process in Australian hospitals: The World Health Organization High 5s project.

Stark HE, Graudins LV, McGuire TM, Lee CYY, Duguid MJ.

Res Social Adm Pharm. 2019 May 23. pii: S1551-7411(18)30962-8. doi: 10.1016/j.sapharm.2019.05.011. [Epub ahead of print]

PMID:
31176651
2.

Nature-inspired pyrrolo[2,3-d]pyrimidines targeting the histamine H3 receptor.

Frank A, Meza-Arriagada F, Salas CO, Espinosa-Bustos C, Stark H.

Bioorg Med Chem. 2019 May 29. pii: S0968-0896(19)30431-6. doi: 10.1016/j.bmc.2019.05.042. [Epub ahead of print]

PMID:
31176569
3.

Chemotaxis in a binary mixture of active and passive particles.

Stürmer J, Seyrich M, Stark H.

J Chem Phys. 2019 Jun 7;150(21):214901. doi: 10.1063/1.5080543.

PMID:
31176313
4.

Structural and Functional Analyses of the Human PDH Complex Suggest a "Division-of-Labor" Mechanism by Local E1 and E3 Clusters.

Prajapati S, Haselbach D, Wittig S, Patel MS, Chari A, Schmidt C, Stark H, Tittmann K.

Structure. 2019 Apr 26. pii: S0969-2126(19)30131-5. doi: 10.1016/j.str.2019.04.009. [Epub ahead of print]

PMID:
31130485
5.

Histamine H3 receptor antagonists/inverse agonists: Where do they go?

Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M.

Pharmacol Ther. 2019 Apr 24. pii: S0163-7258(19)30070-1. doi: 10.1016/j.pharmthera.2019.04.007. [Epub ahead of print] Review.

PMID:
31028835
6.

Cognitive Improvements in Children with Prader-Willi Syndrome Following Pitolisant Treatment-Patient Reports.

Pullen LC, Picone M, Tan L, Johnston C, Stark H.

J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):166-171. doi: 10.5863/1551-6776-24.2.166.

7.

Time-Resolved Measurements of Indoor Chemical Emissions, Deposition, and Reactions in a University Art Museum.

Pagonis D, Price DJ, Algrim LB, Day DA, Handschy AV, Stark H, Miller SL, de Gouw J, Jimenez JL, Ziemann PJ.

Environ Sci Technol. 2019 May 7;53(9):4794-4802. doi: 10.1021/acs.est.9b00276. Epub 2019 Apr 26.

PMID:
30990681
8.

Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus.

Salem A, Almahmoudi R, Hagström J, Stark H, Nordström D, Salo T, Eklund KK.

Int J Mol Sci. 2019 Apr 10;20(7). pii: E1780. doi: 10.3390/ijms20071780.

9.

Experimental autoimmune myocarditis in rats and therapeutic histamine H1 - H4 receptor inhibition.

Stasiak A, Gola J, Kraszewska K, Mussur M, Kobos J, Mazurek U, Stark H, Fogel WA.

J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.13. Epub 2019 Mar 18.

10.

Investigation of the retention forces of secondary telescopic crowns made from Pekkton® ivory in combination with primary crowns made from four different dental alloys: an in vitro study.

Kotthaus M, Hasan I, Keilig L, Grüner M, Bourauel C, Stark H.

Biomed Tech (Berl). 2019 Mar 15. pii: /j/bmte.ahead-of-print/bmt-2018-0167/bmt-2018-0167.xml. doi: 10.1515/bmt-2018-0167. [Epub ahead of print]

PMID:
30875315
11.

Role of Histamine H₃ Receptor Antagonists on Intraocular Pressure Reduction in Rabbit Models of Transient Ocular Hypertension and Glaucoma.

Lanzi C, Lucarini L, Durante M, Sgambellone S, Pini A, Catarinicchia S, Łażewska D, Kieć-Kononowicz K, Stark H, Masini E.

Int J Mol Sci. 2019 Feb 24;20(4). pii: E981. doi: 10.3390/ijms20040981.

12.

Alkyl derivatives of 1,3,5-triazine as histamine H4 receptor ligands.

Łażewska D, Mogilski S, Hagenow S, Kuder K, Głuch-Lutwin M, Siwek A, Więcek M, Kaleta M, Seibel U, Buschauer A, Filipek B, Stark H, Kieć-Kononowicz K.

Bioorg Med Chem. 2019 Apr 1;27(7):1254-1262. doi: 10.1016/j.bmc.2019.02.020. Epub 2019 Feb 12.

PMID:
30792106
13.

Structural Insights into Nuclear pre-mRNA Splicing in Higher Eukaryotes.

Kastner B, Will CL, Stark H, Lührmann R.

Cold Spring Harb Perspect Biol. 2019 Feb 14. pii: a032417. doi: 10.1101/cshperspect.a032417. [Epub ahead of print]

PMID:
30765414
14.

A flowing pair of particles in inertial microfluidics.

Schaaf C, Rühle F, Stark H.

Soft Matter. 2019 Feb 27;15(9):1988-1998. doi: 10.1039/c8sm02476f.

PMID:
30714602
15.

Ligand binding kinetics at histamine H3 receptors by fluorescence-polarization with real-time monitoring.

Reiner D, Stark H.

Eur J Pharmacol. 2019 Apr 5;848:112-120. doi: 10.1016/j.ejphar.2019.01.041. Epub 2019 Jan 28.

PMID:
30703360
16.

Comprehensive three-dimensional morphology of neoangiogenesis in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.

Neubert L, Borchert P, Shin HO, Linz F, Wagner WL, Warnecke G, Laenger F, Haverich A, Stark H, Hoeper MM, Kuehnel M, Ackermann M, Jonigk D.

J Pathol Clin Res. 2019 Apr;5(2):108-114. doi: 10.1002/cjp2.125. Epub 2019 Feb 27.

17.

One-megadalton metalloenzyme complex in Geobacter metallireducens involved in benzene ring reduction beyond the biological redox window.

Huwiler SG, Löffler C, Anselmann SEL, Stärk HJ, von Bergen M, Flechsler J, Rachel R, Boll M.

Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2259-2264. doi: 10.1073/pnas.1819636116. Epub 2019 Jan 23.

PMID:
30674680
18.

Determining phoretic mobilities with Onsager's reciprocal relations: Electro- and thermophoresis revisited.

Burelbach J, Stark H.

Eur Phys J E Soft Matter. 2019 Jan 10;42(1):4. doi: 10.1140/epje/i2019-11769-y.

PMID:
30643995
19.

Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.

Faisal M, Stark H, Büsche G, Schlue J, Teiken K, Kreipe HH, Lehmann U, Bartels S.

Cancer Med. 2019 Feb;8(2):742-750. doi: 10.1002/cam4.1946. Epub 2019 Jan 11.

20.

Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies.

Morris AP, Le TH, Wu H, Akbarov A, van der Most PJ, Hemani G, Smith GD, Mahajan A, Gaulton KJ, Nadkarni GN, Valladares-Salgado A, Wacher-Rodarte N, Mychaleckyj JC, Dueker ND, Guo X, Hai Y, Haessler J, Kamatani Y, Stilp AM, Zhu G, Cook JP, Ärnlöv J, Blanton SH, de Borst MH, Bottinger EP, Buchanan TA, Cechova S, Charchar FJ, Chu PL, Damman J, Eales J, Gharavi AG, Giedraitis V, Heath AC, Ipp E, Kiryluk K, Kramer HJ, Kubo M, Larsson A, Lindgren CM, Lu Y, Madden PAF, Montgomery GW, Papanicolaou GJ, Raffel LJ, Sacco RL, Sanchez E, Stark H, Sundstrom J, Taylor KD, Xiang AH, Zivkovic A, Lind L, Ingelsson E, Martin NG, Whitfield JB, Cai J, Laurie CC, Okada Y, Matsuda K, Kooperberg C, Chen YI, Rundek T, Rich SS, Loos RJF, Parra EJ, Cruz M, Rotter JI, Snieder H, Tomaszewski M, Humphreys BD, Franceschini N.

Nat Commun. 2019 Jan 3;10(1):29. doi: 10.1038/s41467-018-07867-7.

21.

Histamine H3 receptor ligands by hybrid virtual screening, docking, molecular dynamics simulations, and investigation of their biological effects.

Ghamari N, Zarei O, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M.

Chem Biol Drug Des. 2019 May;93(5):832-843. doi: 10.1111/cbdd.13471. Epub 2019 Jan 24.

PMID:
30586225
22.

3.5  kW coherently combined ultrafast fiber laser.

Müller M, Klenke A, Steinkopff A, Stark H, Tünnermann A, Limpert J.

Opt Lett. 2018 Dec 15;43(24):6037-6040. doi: 10.1364/OL.43.006037.

PMID:
30547999
23.

Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield.

Thomson KL, Ormondroyd E, Harper AR, Dent T, McGuire K, Baksi J, Blair E, Brennan P, Buchan R, Bueser T, Campbell C, Carr-White G, Cook S, Daniels M, Deevi SVV, Goodship J, Hayesmoore JBG, Henderson A, Lamb T, Prasad S, Rayner-Matthews P, Robert L, Sneddon L, Stark H, Walsh R, Ware JS, Farrall M, Watkins HC; NIHR BioResource – Rare Diseases Consortium.

Genet Med. 2018 Dec 11. doi: 10.1038/s41436-018-0375-z. [Epub ahead of print]

24.

Posing the APC/C E3 Ubiquitin Ligase to Orchestrate Cell Division.

Watson ER, Brown NG, Peters JM, Stark H, Schulman BA.

Trends Cell Biol. 2019 Feb;29(2):117-134. doi: 10.1016/j.tcb.2018.09.007. Epub 2018 Oct 25. Review.

PMID:
30482618
25.

Optimization and preclinical evaluation of novel histamine H3receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives.

Szczepańska K, Karcz T, Kotańska M, Siwek A, Kuder KJ, Latacz G, Mogilski S, Hagenow S, Lubelska A, Sobolewski M, Stark H, Kieć-Kononowicz K.

Bioorg Med Chem. 2018 Dec 15;26(23-24):6056-6066. doi: 10.1016/j.bmc.2018.11.010. Epub 2018 Nov 10.

PMID:
30448256
26.

[Injury patterns in interstitial lung diseases].

Länger F, Stark H, Braubach P, Ackermann M, Hussein K, Teiken K, Maegel L, Kuehnel M, Jonigk D.

Pathologe. 2018 Dec;39(Suppl 2):262-271. doi: 10.1007/s00292-018-0503-1. Review. German.

PMID:
30397788
27.

Studies on Anticonvulsant Effects of Novel Histamine H3R Antagonists in Electrically and Chemically Induced Seizures in Rats.

Alachkar A, Łażewska D, Latacz G, Frank A, Siwek A, Lubelska A, Honkisz-Orzechowska E, Handzlik J, Stark H, Kieć-Kononowicz K, Sadek B.

Int J Mol Sci. 2018 Oct 29;19(11). pii: E3386. doi: 10.3390/ijms19113386.

28.

Impact of shortened dental arch on oral health-related quality of life over a period of 10 years - A randomized controlled trial.

Reissmann DR, Wolfart S, John MT, Marré B, Walter M, Kern M, Kohal R, Nothdurft F, Stark H, Schierz O, Wöstmann B, Hannak W, Mundt T, Pospiech P, Boldt J, Edelhoff D, Busche E, Jahn F, Luthardt RG, Hartmann S, Heydecke G.

J Dent. 2019 Jan;80:55-62. doi: 10.1016/j.jdent.2018.10.006. Epub 2018 Oct 21.

PMID:
30355509
29.

Artificial Chemotaxis of Self-Phoretic Active Colloids: Collective Behavior.

Stark H.

Acc Chem Res. 2018 Nov 20;51(11):2681-2688. doi: 10.1021/acs.accounts.8b00259. Epub 2018 Oct 16.

PMID:
30346724
30.

Correction: Feedback control of photoresponsive fluid interfaces.

Grawitter J, Stark H.

Soft Matter. 2018 Sep 11;14(35):7287. doi: 10.1039/c8sm90147c.

PMID:
30159578
31.

Differential effects of functionally different histamine H4 receptor ligands on acute irritant dermatitis in mice.

Adami M, Micheloni C, Grandi D, Stark H.

Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec;391(12):1387-1397. doi: 10.1007/s00210-018-1553-x. Epub 2018 Aug 25.

PMID:
30145688
32.

Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor.

Frank A, Kiss DJ, Keserű GM, Stark H.

Sci Rep. 2018 Aug 21;8(1):12509. doi: 10.1038/s41598-018-30794-y.

33.

Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds.

Proschak E, Stark H, Merk D.

J Med Chem. 2019 Jan 24;62(2):420-444. doi: 10.1021/acs.jmedchem.8b00760. Epub 2018 Aug 3.

PMID:
30035545
34.

The Anaphylatoxin C3a Receptor Expression on Human M2 Macrophages Is Down-Regulated by Stimulating the Histamine H4 Receptor and the IL-4 Receptor.

Mommert S, Aslan D, Ratz L, Stark H, Gutzmer R, Werfel T.

J Innate Immun. 2018;10(4):349-362. doi: 10.1159/000490426. Epub 2018 Jul 20.

35.

New lead elements for histamine H3 receptor ligands in the pyrrolo[2,3-d]pyrimidine class.

Espinosa-Bustos C, Frank A, Arancibia-Opazo S, Salas CO, Fierro A, Stark H.

Bioorg Med Chem Lett. 2018 Sep 15;28(17):2890-2893. doi: 10.1016/j.bmcl.2018.07.023. Epub 2018 Jul 17.

PMID:
30025902
36.

Selenazolyl-hydrazones as Novel Selective MAO Inhibitors With Antiproliferative and Antioxidant Activities: Experimental and In-silico Studies.

Elshaflu H, Todorović TR, Nikolić M, Lolić A, Višnjevac A, Hagenow S, Padrón JM, García-Sosa AT, Djordjević IS, Grubišić S, Stark H, Filipović NR.

Front Chem. 2018 Jul 3;6:247. doi: 10.3389/fchem.2018.00247. eCollection 2018.

37.

Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H3R ligands.

Khanfar MA, Reiner D, Hagenow S, Stark H.

Bioorg Med Chem. 2018 Aug 7;26(14):4034-4046. doi: 10.1016/j.bmc.2018.06.028. Epub 2018 Jun 21.

PMID:
29960729
38.

Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation.

Kraus D, Reckenbeil J, Veit N, Kuerpig S, Meisenheimer M, Beier I, Stark H, Winter J, Probstmeier R.

Cell Oncol (Dordr). 2018 Oct;41(5):485-494. doi: 10.1007/s13402-018-0385-5. Epub 2018 Jun 11.

PMID:
29949049
39.

Four Molybdenum-Dependent Steroid C-25 Hydroxylases: Heterologous Overproduction, Role in Steroid Degradation, and Application for 25-Hydroxyvitamin D3 Synthesis.

Jacoby C, Eipper J, Warnke M, Tiedt O, Mergelsberg M, Stärk HJ, Daus B, Martín-Moldes Z, Zamarro MT, Díaz E, Boll M.

MBio. 2018 Jun 19;9(3). pii: e00694-18. doi: 10.1128/mBio.00694-18.

40.

Cryo-EM in drug discovery: achievements, limitations and prospects.

Renaud JP, Chari A, Ciferri C, Liu WT, Rémigy HW, Stark H, Wiesmann C.

Nat Rev Drug Discov. 2018 Jul;17(7):471-492. doi: 10.1038/nrd.2018.77. Epub 2018 Jun 8. Review.

PMID:
29880918
41.

PEKK-made indirect temporary crowns and bridges: a clinical pilot study.

Klur T, Hasan I, Ottersbach K, Stark H, Fichte M, Dirk C, Bourauel C.

Clin Oral Investig. 2019 Feb;23(2):771-777. doi: 10.1007/s00784-018-2493-z. Epub 2018 May 30.

PMID:
29850956
42.

Structural Characterization and Photochemical Properties of Mono- and Bimetallic Cu-Mabiq Complexes.

Stark HS, Altmann PJ, Sproules S, Hess CR.

Inorg Chem. 2018 Jun 4;57(11):6401-6409. doi: 10.1021/acs.inorgchem.8b00471. Epub 2018 May 16.

PMID:
29767971
43.

Simulating squirmers with multiparticle collision dynamics.

Zöttl A, Stark H.

Eur Phys J E Soft Matter. 2018 May 15;41(5):61. doi: 10.1140/epje/i2018-11670-3.

PMID:
29766348
44.

Anticonvulsant evaluation of novel non-imidazole histamine H3R antagonists in different convulsion models in rats.

Alachkar A, Latacz G, Siwek A, Lubelska A, Honkisz E, Gryboś A, Łażewska D, Handzlik J, Stark H, Kiec-Kononowicz K, Sadek B.

Pharmacol Biochem Behav. 2018 Jul;170:14-24. doi: 10.1016/j.pbb.2018.04.010. Epub 2018 May 3.

PMID:
29729290
45.

Synthesis and biological activity of novel tert-butyl and tert-pentylphenoxyalkyl piperazine derivatives as histamine H3R ligands.

Szczepańska K, Karcz T, Mogilski S, Siwek A, Kuder KJ, Latacz G, Kubacka M, Hagenow S, Lubelska A, Olejarz A, Kotańska M, Sadek B, Stark H, Kieć-Kononowicz K.

Eur J Med Chem. 2018 May 25;152:223-234. doi: 10.1016/j.ejmech.2018.04.043. Epub 2018 Apr 25.

PMID:
29723785
46.

Sequential phase locking scheme for a filled aperture intensity coherent combination of beam arrays.

Klenke A, Müller M, Stark H, Tünnermann A, Limpert J.

Opt Express. 2018 Apr 30;26(9):12072-12080.

PMID:
29716123
47.

Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation.

Łażewska D, Kaleta M, Hagenow S, Mogilski S, Latacz G, Karcz T, Lubelska A, Honkisz E, Handzlik J, Reiner D, Satała G, Filipek B, Stark H, Kieć-Kononowicz K.

Bioorg Med Chem. 2018 May 15;26(9):2573-2585. doi: 10.1016/j.bmc.2018.04.023. Epub 2018 Apr 11.

PMID:
29681486
48.

Coherently combined 16-channel multicore fiber laser system.

Klenke A, Müller M, Stark H, Stutzki F, Hupel C, Schreiber T, Tünnermann A, Limpert J.

Opt Lett. 2018 Apr 1;43(7):1519-1522. doi: 10.1364/OL.43.001519.

PMID:
29601019
49.

The histamine H4 receptor modulates the differentiation process of human monocyte-derived M1 macrophages and the release of CCL4/MIP-1β from fully differentiated M1 macrophages.

Mommert S, Ratz L, Stark H, Gutzmer R, Werfel T.

Inflamm Res. 2018 Jun;67(6):503-513. doi: 10.1007/s00011-018-1140-0. Epub 2018 Mar 29.

PMID:
29600327
50.

Antinociceptive effects of novel histamine H3 and H4 receptor antagonists and their influence on morphine analgesia of neuropathic pain in the mouse.

Popiolek-Barczyk K, Łażewska D, Latacz G, Olejarz A, Makuch W, Stark H, Kieć-Kononowicz K, Mika J.

Br J Pharmacol. 2018 Jul;175(14):2897-2910. doi: 10.1111/bph.14185. Epub 2018 May 31.

PMID:
29486058

Supplemental Content

Support Center